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~The Cystic Fibrosis interactive CD-ROM 
C. Geddes, N. Bertone. Department of Physiotherapy, Southern Health Monash 
Medical Centre, Melbourne, Australia 
Introduction: Young people with Cystic Fibrosis (CF) self-manage components 
of their disease with the aim of slowing disease progression and to maintain 
their quality of life. Physiotherapy, including airway clearance techniques, exercise 
therapy and inhalation therapy, is a large component of self-management. 
Aim: To identify adherence and participation barriers among adolescent and young 
adult patients with CF, using a modified validated questionnaire, and to develop a 
patient supported solution. 
Method: Questionnaires were administered to the 33 patients aged 15 25yrs in the 
Southern Health CF patient population. 19 responses were received and thematic 
analysis was used to identify some key barriers to physiotherapy. A CD-ROM was 
then developed and distributed to the Southern Health CF population. 
Results: The identified barriers to physiotherapy included lack of time due to 
school/work commitments, poor access to information and reluctance to access 
information. Accessible computer-based or written information about physiotherapy 
was considered to be beneficial for physiotherapy adherence. The use of computer- 
based technology was deemed to be helpful in the acquisition of physiotherapy 
specific knowledge. 
Conclusion: This population identified time pressures, lack of accessible informa- 
tion and reluctance to seek information as barriers to adherence with physiotherapy. 
A computer-based education program is believed, by the patient group surveyed, to 
be of assistance in promoting physiotherapy self management i  CE 
Future Direction: A follow up questionnaire is currently being distributed to the 
CF population to gather feedback about the CD-ROM. This information will be 
available prior to the conference but is unable to be presented in this abstract. 
9. Physiotherapy 
1~ Chest strength and mobility training: a new approach to airways 
clearance 
A. Demry 1, S. Ben Ami 1 , M. Levi 1 , I. Eizenstadt 2, E. Kerem 2, J. Yahav 3, 
A. Avital 4, H. Blau 5. 1 Tamar Institute for Physical Therapy and Pulmonary 
Rehabilitation, Tel Aviv; 2 CF Center, Hadassah, Mr. Scopus, .Jerusalem; 
3 CF Center, Sheba, Tel Hashomer; 4 CF Center, Hadassah, Ein Kerem, Jerusalem; 
5Schneider Children ~' Med Cr, Petah Tikva, Israel 
Aims: To evaluate the effect of a new approach to airway clearance: mobilizing 
and strengthening chest and trunk muscles and joints, releasing chest restriction in 
order to ultimately improve lung function. 
Methods: 14 patients aged 14 45 y were recruited from Israeli CF centers. Three 
were excluded because of insufficient hospital clinic visits and data. Patients were 
treated 1 3 times/week for 1 hour. Exercises combined stretching and strengthening 
the chest, back and abdominal muscles, in order to mobilize the chest, and improve 
the diaphragmatic length tension curve. The program included balance and weight- 
bearing exercises to improve coordination and posture. Retrospective chart review 
compared slope of change of FEV1 and number of pulmonary exacerbations 
requiring intravenous antibiotics over 1 year preceding and 1 year following the 
intervention. 
Results: In all patients there was a marked improvement in posture, chest wall 
mobility and body strength as well as subjective improvement in well-being. The 
slope of the linear regression of FEV1 over time improved significantly from 
0.5% in the year before the program, to +0.2% over the year following onset of 
the intervention (p < 0.03). The mean number of pulmonary exacerbations requiring 
intravenous antibiotics fell from 2.7/year before the program to 1.6/year after the 
intervention (p < 0.03). 
Conclusions: Chest strength and mobility training is an effective new approach to 
treating lung disease in CF, decreasing exacerbations and lung function deterioration 
while improving body strength and chest wall functions. 
• Acute hypercapnic respiratory failure secondary to substance 
abuse in Cystic Fibrosis adults 
L. Gumery, R. MacDonald, D. Honeybourne, M. Wildman. West Midlands Adult 
CF Centre, Heart of England NHS Trust, UK 
Background: Substance abuse (SA) is known to increase the risk of respiratory 
pump dysfunction through central nervous ystem depression and respiratory muscle 
fatigue [1,2]. Several CF adults presenting with acute hypercapnic respiratory failure 
(AHRF) revealed SA on questioning during physiotherapy assessment. 
Aim: To heighten awareness of SA contributing to AHRF, promote sensitive 
discussion and enhance referral for treatment and counselling. 
Method: A retrospective search of medical notes of 7 cases of AHRF with 
SA identified the substances abused, AHRF incidence/patient, pulmonary/systemic 
complications and outcome. 
Results: Smoking cigarettes and cannabis were commenced by 6/7 age 9 16yrs. 
Substances used ranged from cannabis (5/7) to heroin (3/7). AHRF due to SA 
ranged from 1 episode (6/7) to 9 episodes (1/7). Pulmonary complications included 
severe bronchospasm, haemoptysis, aspiration, and respiratory arrest. Systemic 
complications included fatal gastric bleed and cardiac arrest. Patient outcome ranged 
from full recovery from AHRF (3/7) to death (4/7). Successful rehabilitation was 
completed by (2/3) of heroin users. 
Conclusion: AHRF secondary to SA in CF adults was highlighted, which improved 
awareness leading to early recognition/treatment. I  future this may lead to the 
offer of early referral to counselling/rehabilitation, which may prevent AHRF due 
to substance abuse and improve long term outcome. 
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I • A  5 year study of newly diagnosed CF patients in a screened 
population 
J. Murray, J. McCaughan, A. Leavy, A. Reid. Paediatric CF Centre Royal Belfast 
Hospital for Sick Children, Belftst, Ni Ireland, UK 
Aims: To find out how many patients diagnosed with CF in Northern Ireland in the 
last 5 years were symptomatic or asymptomatic ondiagnosis. Did the asymptomatic 
patients become symptomatic over time and did the reverse occur? 
Method: A retrospective study of all patients'medical charts, annual assessment 
data details and physiotherapy notes was undertaken. 40 patients newly diagnosed 
with CF, born from 2000 to 2004 inclusive were studied. 4 symptoms were counted 
cough, secretions present, wheeze and shortness of breath. If symptoms were present 
at diagnosis and at follow up review more than 50% in one year, they were counted 
as symptomatic. Other details that might have a bearing on symptoms were also 
noted; mode of diagnosis, mutations identified, bacterial status at diagnosis pre 
administration f prophylactic anti-staphlococcal antibiotic and continued bacterial 
status at each review, acquisition of viral infections and admissions over the 5 years. 
Results: 28/40 patients were symptomatic at diagnosis. 8/28 are now improved 
in status and are considered asymptomatic. The 12/40 asymptomatic patients at 
diagnosis developed symptoms over their first year and as they became older 
presented with only minimal symptoms occurring infrequently. 
Conclusions: 12 patients who were asymptomatic at diagnosis became symptomatic 
in their first year, it seems reasonable tocommence treatment a  diagnosis rather than 
on symptoms when a greater level of parental anxiety may hinder their competency 
with techniques. It is reasonable also to be nonprescriptive with frequent reviews 
and assessments, o reduce or change the focus of treatment. 
